Strive, Inc., formerly known as Asset Entities Inc., trades on Nasdaq under the ticker ASST and positions itself as the first publicly traded asset management Bitcoin treasury company. Co-founded by Vivek Ramaswamy and led by Chairman and CEO Matt Cole, Strive came together through a September 2025 merger between Asset Entities and Strive Enterprises, then added a meaningful Bitcoin position via a combination with Semler Scientific in early 2026. The company runs an SEC-registered investment adviser subsidiary, Strive Asset Management, that oversees exchange-traded funds, yet its primary focus has shifted to raising capital through common and preferred equity to buy and hold Bitcoin, with the long-term aim of growing Bitcoin per share.
Over the last 30 days, ASST has fallen approximately 30%, moving from a closing price of $30.03 on October 2 to about $21.04 in early November. The decline was sharp, with the stock pulling back from a late-September peak above $30 even while the company kept adding Bitcoin. This contrasts with the broader trailing-quarter trend: roughly three months ago in early August the stock traded near $12, so it remains up about 69% over that span despite the recent pullback. In short, the last 30 days represent a high-volatility correction inside a still-positive multi-month uptrend. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The 30-day decline stemmed less from Bitcoin headlines and more from the mechanics of financing those purchases. In mid-October, holders exercised roughly 13.7 million traditional PIPE warrants, generating about $369 million in proceeds but expanding the effective common share count from about 110.4 million to 124.1 million shares. That dilution muted the benefit of the additional Bitcoin for existing shareholders. Around the same time, Strive priced a $630 million offering of its 15% Series A Perpetual SATS preferred stock. While the capital funds further Bitcoin purchases, the fixed dividend obligation sits ahead of common equity and raised concerns about the cost of the financing model. Separately, Bitcoin traded below the company’s blended cost basis, estimated in the high $80,000s to low $90,000s per coin, and insider selling tied to tax obligations on vested restricted stock units added pressure. These headwinds outweighed supportive analyst actions, including a price-target increase by TD Cowen and a higher target from StoneX.
The quarterly story centers on rapid expansion. Strive entered 2026 with a comparatively modest Bitcoin position and, through preferred stock issuance, warrant exercises, and cash, scaled its holdings to roughly 43,000 BTC by early November, placing it among the largest public corporate Bitcoin holders behind firms such as Strategy (MSTR) and Metaplanet. Bitcoin’s strong late-summer rally, which carried the asset above $86,000, amplified the value of that growing treasury and helped lift ASST from the low teens into the high $20s and low $30s. The quarter reflects a powerful accumulation narrative that eventually ran into financing, dilution, and asset-price headwinds late in the period.
Several factors are likely to shape ASST’s direction in the near term. Investors should monitor Strive’s upcoming earnings report and its treasury disclosures, which detail both Bitcoin holdings and the pace of new share issuance. The start of daily dividends on the SATS preferred stock adds a recurring cash obligation worth watching. Most importantly, the trajectory of Bitcoin’s price relative to Strive’s cost basis will heavily influence the value of its treasury and investor sentiment. Financing activity, including any new preferred stock or at-the-market sales, will also matter. Broader regulatory developments, institutional adoption of digital assets, and competition from peers such as MARA Holdings (MARA) will continue to shape the sector backdrop. These are risk factors to observe rather than signals of future returns. From what I see, tracking these elements through tools like Tickeron’s AI Trend Prediction Engine helps clarify the setup.
When analyzing names like ASST, I often turn to Tickeron’s AI Daily Buy/Sell Signals to get a quick sense of current momentum and how the stock stacks up against peers. It gives me another data point without replacing my own fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.
ASST saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 63 similar instances where the indicator turned negative. In 59 of the 63 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
ASST moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ASST crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The RSI Indicator entered the oversold zone -- be on the watch for ASST's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +4.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASST advanced for three days, in 140 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
ASST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 64 of 78 cases where ASST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. ASST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.143) is normal, around the industry mean (2.420). P/E Ratio (-28.065) is within average values for comparable stocks, (-3.848). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.268) among similar stocks. ASST's P/S Ratio (113.636) is very high in comparison to the industry average of (15.694).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers